Loading...
•
Mar 31, 2022
Akoya Q1 2022 Earnings Report
Akoya reported record revenue and system placements, driven by the commercial launch of the PhenoCycler-Fusion System and execution across all business segments.
Key Takeaways
Akoya Biosciences reported a 38% increase in total revenue for Q1 2022, reaching $16.9 million compared to $12.2 million in the prior year period. The company also raised its full year 2022 revenue guidance to a range of $70-73 million.
Total revenue increased by 38% to $16.9 million compared to the prior year period.
Product revenue increased by 34% to $13.3 million, with reagent revenue increasing by 82%.
Services and other revenue increased by 58% to $3.6 million.
Gross profit increased by 36% to $10.1 million, with a gross profit margin of 60%.
Akoya
Akoya
Akoya Revenue by Segment
Revenue by Segment
Product Revenue
CapyFin.comService and other Revenue
CapyFin.com Forward Guidance
The company is raising its full year 2022 revenue guidance range to $70-73 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income